We sit down with Biopharma expert Ivan Kairatov to discuss a recent study that uncovers a critical vulnerability in acute myeloid leukemia (AML), a notoriously difficult-to-treat blood cancer. This research zeroes in on the survival mechanisms of resilient leukemia stem cells, identifying a key
The advent of immune checkpoint inhibitors heralded a new dawn in cancer treatment, yet their promise remains unfulfilled for the vast majority of patients who show little to no response to these potentially life-saving drugs. This central paradox has left clinicians and researchers searching for a
A single class of molecules exists at the very heart of cellular life, acting as both a catalyst for vibrant growth and a quiet harbinger of decline, a duality that has long puzzled the scientific community. These molecules, known as polyamines, are fundamental to the function of every living cell,
As millions of people around the globe clock in for shifts that extend into the late hours and overnight, a large-scale study has revealed a concerning and previously underappreciated occupational hazard connected to their work schedules. This comprehensive investigation provides significant new
Today we are speaking with Ivan Kairatov, a biopharma expert whose work at the intersection of public health and cancer epidemiology sheds light on one of the world’s most preventable cancers. We’ll be exploring the complex story behind cervical cancer: a disease for which we have the tools to
The ability to track cancer's genetic secrets through a simple blood draw is no longer a futuristic concept but a clinical reality facing its own set of critical challenges. For years, the field of oncology has been steadily moving away from invasive tissue biopsies toward liquid biopsies, a
